Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Even With Undetectable PSA, Men With Locally Advanced Prostate Cancer Benefit From Adjuvant Radiatio
Link ID 16867
Title Even With Undetectable PSA, Men With Locally Advanced Prostate Cancer Benefit From Adjuvant Radiatio
Url http://www.medscape.com/viewarticle/704911?src=rss
Description A new study provides further evidence of the benefit of adjuvant radiation in men who have undergone radical prostatectomy and who have stage T3 disease. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Jun 26, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Researchers Urge New Immunotherapy End Points
  Scientists who developed ipilimumab for metastatic melanoma say we need a new approach to cancer immunotherapy trials. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. A Reader Responds to "Seven Pharmacotherapies Do Promote Smoking Abstinence at 6 and 12 Months"
  A reader discusses the need to systematically study human health hazards of nonconventional methods of using tobacco.
The Medscape Journal of Medicine
Category:   Articles > Hematology-Oncology


3. Scientists Discover Neuroblastoma Gene
  The author discusses new findings about a genetic cause of neuroblastoma.
Medscape Genomic Medicine
Category:   Articles > Hematology-Oncology


4. Rituximab Extends Progression-Free Survival in Follicular Lymphoma
  Patients with follicular lymphoma receiving rituximab maintenance therapy had significantly better progression-free survival but not overall survival. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. EML4-ALK as a Predictive Marker for Response to EGFR Therapy
  Dr. Maurie Markman comments on a study published in the Journal of Clinical Oncology describing the use of the EML4-ALK fusion oncogene to predict response to EGFR therapy in patients with NSCLC. Medscape Genomic Medicine
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS